As of 2025-05-22, the Relative Valuation of Eli Lilly and Co (LLY) is 251.43 USD. This relative valuation is based on P/E multiples. With the latest stock price at 724.95 USD, the upside of Eli Lilly and Co based on Relative Valuation is -65.3%.
The range of the Relative Valuation is 202.21 - 300.63 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 25.7x | 20.7x |
| Forward P/E multiples | 18.1x - 21.6x | 19.6x |
| Fair Price | 202.21 - 300.63 | 251.43 |
| Upside | -72.1% - -58.5% | -65.3% |
| Date | P/E |
| 2025-05-21 | 61.88 |
| 2025-05-20 | 63.76 |
| 2025-05-19 | 64.45 |
| 2025-05-16 | 64.65 |
| 2025-05-15 | 62.59 |
| 2025-05-14 | 61.08 |
| 2025-05-13 | 63.68 |
| 2025-05-12 | 64.49 |
| 2025-05-09 | 62.70 |
| 2025-05-08 | 64.14 |
| 2025-05-07 | 66.30 |
| 2025-05-06 | 66.16 |
| 2025-05-05 | 70.12 |
| 2025-05-02 | 70.30 |
| 2025-05-01 | 67.78 |
| 2025-04-30 | 76.73 |
| 2025-04-29 | 75.56 |
| 2025-04-28 | 74.88 |
| 2025-04-25 | 75.50 |
| 2025-04-24 | 73.38 |
| 2025-04-23 | 70.80 |
| 2025-04-22 | 70.63 |
| 2025-04-21 | 69.82 |
| 2025-04-17 | 71.70 |
| 2025-04-16 | 62.73 |
| 2025-04-15 | 64.63 |
| 2025-04-14 | 64.39 |
| 2025-04-11 | 62.52 |
| 2025-04-10 | 61.53 |
| 2025-04-09 | 64.33 |
| 2025-04-08 | 61.99 |
| 2025-04-07 | 61.77 |
| 2025-04-04 | 63.01 |
| 2025-04-03 | 67.35 |
| 2025-04-02 | 69.84 |
| 2025-04-01 | 68.73 |
| 2025-03-31 | 70.50 |
| 2025-03-28 | 70.21 |
| 2025-03-27 | 70.13 |
| 2025-03-26 | 70.57 |
| 2025-03-25 | 72.75 |
| 2025-03-24 | 73.82 |
| 2025-03-21 | 71.49 |
| 2025-03-20 | 71.92 |
| 2025-03-19 | 71.44 |
| 2025-03-18 | 70.21 |
| 2025-03-17 | 70.40 |
| 2025-03-14 | 69.43 |
| 2025-03-13 | 68.43 |
| 2025-03-12 | 70.15 |